United Therapeutics reported $37.2M in Cost of Sales for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Amarin AMRN:US USD 23.94M 11.87M
Ardelyx ARDX:US USD 732K 594K
Baxter International BAX:US USD 2.63B 337M
Bayer BAYN:GR EUR 4.25B 1.43B
Biocryst Pharmaceuticals BCRX:US USD 3.61M 3.37M
Biogen BIIB:US USD 469.5M 14.5M
Biomarin Pharmaceutical BMRN:US USD 116.29M 6.84M
Emergent Biosolutions EBS:US USD 148.6M 21.2M
Esperion Therapeutics ESPR:US USD 6.51M 2.67M
Gilead Sciences GILD:US USD 1.4B 1000K
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Halozyme Therapeutics HALO:US USD 47.32M 13.38M
Insmed INSM:US USD 13.47M 2.92M
Intercept Pharmaceuticals ICPT:US USD 424K 115K
Intra Cellular Therapies ITCI:US USD 5.85M 1.2M
Johnson & Johnson JNJ:US USD 7.76B 29M
Moderna Inc MRNA:US USD 1.1B 281M
Pfizer PFE:US USD 9.82B 3.73B
Ptc Therapeutics PTCT:US USD 14.01M 4.37M
Regeneron Pharmaceuticals REGN:US USD 540.6M 222.8M
Sarepta Therapeutics SRPT:US USD 39.95M 2.16M
Seattle Genetics SGEN:US USD 108.12M 2.02M
Teva Pharmaceutical TEVA:IT USD 1.88B 73M
United Therapeutics UTHR:US USD 37.2M 7.5M
Vertex Pharmaceuticals VRTX:US USD 289.4M 27.6M